SeekPeptides members use protocol tracking tools and community support to optimize their research outcomes
Many international patients have requested consultations
MEDI4166 demonstrates extended glucose control, delays development of diabetes and reduces obesity in rodent models To investigate if the optimised in vivo stability and reduced potency of the MEDI4166 GLP-1 peptide component translates into prolonged glucose control, we compared the impact of MEDI4166 and exendin-4 in fusion with the same antibody partner (Ab#2.1_EX4) on fasting plasma glucose (FPG) levels in moderately hyperglycaemic diet-induced obese (DIO) mice over 21 days (Fig
Hence, addressing the efforts to the research of peculiar salivary molecules will provide clinicians an unprecedented opportunity to soften the painful path of the disease
Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L
We mentioned earlier that it was possible to be insulin resistant, yet not suffer from elevated blood sugar